Floatz logo

Therapeutic Asset Ratings

435 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Cobimetinib
Pancreatic Adenocarcinoma
OHSU Knight Cancer InstituteP1/2CCC (52)
Everolimus
Acute Myeloid Leukemia
OHSU Knight Cancer InstituteP1/2CCC (51)
Vinorelbine
Metastatic Malignant Solid Neoplasm
OHSU Knight Cancer InstituteP1/2CCC (51)
Zn-C3
Primary Peritoneal Carcinoma
OHSU Knight Cancer InstituteP1/2CCC (51)
Abemaciclib
Ovarian Cancer
OHSU Knight Cancer InstituteP2CCC (50)
Entrectinib
Ovarian Cancer
OHSU Knight Cancer InstituteP2CCC (50)
Gdc-0449
Plasma Cell Myeloma
OHSU Knight Cancer InstituteP2CCC (50)
IMMUNOGLOBULIN G1, ANTI-(HUMAN NEU (RECEPTOR)) (HUMAN-MOUSE MONOCLONAL 2C4 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL 2C4 .KAPPA.-CHAIN, DIMER
Plasma Cell Myeloma
OHSU Knight Cancer InstituteP2CCC (50)
Regorafenib
Plasma Cell Myeloma
OHSU Knight Cancer InstituteP2CCC (50)
TANCIN
Pancreatic Neoplasm
OHSU Knight Cancer InstituteP2CCC (50)
Trastuzumab Emtansine
Plasma Cell Myeloma
OHSU Knight Cancer InstituteP2CCC (50)
Vinorelbine
Acute Myeloid Leukemia
OHSU Knight Cancer InstituteP2CCC (50)
Capecitabine
Sarcoma
OHSU Knight Cancer InstituteP1CCC (50)
FULVESTRANT
Pancreatic Cancer for Phase II
OHSU Knight Cancer InstituteP1CCC (50)
Niraparib
Exocrine Pancreatic Carcinoma
OHSU Knight Cancer InstituteP1CCC (50)
Atezolizumab
Advanced Malignant Solid Neoplasm
OHSU Knight Cancer InstituteP1/2CCC (50)
Niraparib
Advanced Malignant Solid Neoplasm
OHSU Knight Cancer InstituteP1/2CCC (50)
gsk1120212
Prostate Cancer
OHSU Knight Cancer InstituteP2CCC (49)
Capecitabine
Advanced Malignant Solid Neoplasm
OHSU Knight Cancer InstituteP1CCC (49)
Irinotecan
Advanced Malignant Solid Neoplasm
OHSU Knight Cancer InstituteP1CCC (49)
TRASTUZUMAB
Stage II Pancreatic Cancer AJCC v8
OHSU Knight Cancer InstituteP1CCC (49)
EXEMESTANE
Prostate Cancer
OHSU Knight Cancer InstituteP2CCC (48)
Entrectinib
Breast Carcinoma
OHSU Knight Cancer InstituteP1CCC (48)
TRASTUZUMAB
Malignant Pancreatic Neoplasm
OHSU Knight Cancer InstituteP1CCC (48)
VEMURAFENIB
Breast Carcinoma
OHSU Knight Cancer InstituteP1CCC (48)
Showing 276 to 300 of 435 assets
PreviousPage 12 of 18Next